Use este identificador para citar o ir al link de este elemento:
http://hdl.handle.net/1843/61816
Registro completo de metadatos
Campo DC | Valor | Idioma |
---|---|---|
dc.creator | Lauren S. Vaughn | pt_BR |
dc.creator | Kenneth Frederick | pt_BR |
dc.creator | Samuel B. Burnett | pt_BR |
dc.creator | Nutan Sharma | pt_BR |
dc.creator | D. Cristopher Bragg | pt_BR |
dc.creator | Sarah Teixeira Camargos | pt_BR |
dc.creator | Francisco Cardoso | pt_BR |
dc.creator | Rekha C. Patel | pt_BR |
dc.date.accessioned | 2023-12-06T19:35:59Z | - |
dc.date.available | 2023-12-06T19:35:59Z | - |
dc.date.issued | 2022 | - |
dc.citation.volume | 12 | pt_BR |
dc.citation.issue | 5 | pt_BR |
dc.identifier.doi | https://doi.org/10.3390/biom12050713 | pt_BR |
dc.identifier.issn | 2218-273X | pt_BR |
dc.identifier.uri | http://hdl.handle.net/1843/61816 | - |
dc.description.resumo | DYT-PRKRA (dystonia 16 or DYT-PRKRA) is caused by mutations in the PRKRA gene that encodes PACT, the protein activator of interferon (IFN)-induced double-stranded (ds) RNA-activated protein kinase (PKR). PACT participates in several cellular pathways, of which its role as a PKR activator protein during integrated stress response (ISR) is the best characterized. Previously, we have established that the DYT-PRKRA mutations cause enhanced activation of PKR during ISR to sensitize DYT-PRKRA cells to apoptosis. In this study, we evaluate if the most prevalent substitution mutation reported in DYT-PRKRA patients alters PACT’s functional role in induction of type I IFNs via the retinoic acid-inducible gene I (RIG-I) signaling. Our results indicate that the P222L mutation augments PACT’s ability to induce IFN β in response to dsRNA and the basal expression of IFN β and IFN-stimulated genes (ISGs) is higher in DYT-PRKRA patient cells compared to cells from the unaffected controls. Additionally, IFN β and ISGs are also induced at higher levels in DYT-PRKRA cells in response to dsRNA. These results offer a new avenue for investigations directed towards understanding the underlying molecular pathomechanisms in DYT-PRKRA. | pt_BR |
dc.format.mimetype | pt_BR | |
dc.language | eng | pt_BR |
dc.publisher | Universidade Federal de Minas Gerais | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | HCL - HOSPITAL DAS CLINICAS | pt_BR |
dc.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | pt_BR |
dc.publisher.initials | UFMG | pt_BR |
dc.relation.ispartof | Biomolecules | pt_BR |
dc.rights | Acesso Aberto | pt_BR |
dc.subject | Dystonia | pt_BR |
dc.subject | DYT16 | pt_BR |
dc.subject | DYT-PRKRA | pt_BR |
dc.subject | PACT | pt_BR |
dc.subject | PRKRA | pt_BR |
dc.subject | PKR | pt_BR |
dc.subject | Interferon | pt_BR |
dc.subject | RIG-I | pt_BR |
dc.subject.other | Distonia | pt_BR |
dc.subject.other | Receptores de Interferon | pt_BR |
dc.subject.other | Interferon Tipo I | pt_BR |
dc.title | DYT-PRKRA Mutation P222L Enhances PACT’s Stimulatory Activity on Type I Interferon Induction | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.url.externa | https://www.mdpi.com/2218-273X/12/5/713 | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0003-2282-6738 | pt_BR |
Aparece en las colecciones: | Artigo de Periódico |
archivos asociados a este elemento:
archivo | Descripción | Tamaño | Formato | |
---|---|---|---|---|
DYT-PRKRA Mutation P222L Enhances PACT’s Stimulatory Activity on Type I Interferon Induction.pdf | 2.2 MB | Adobe PDF | Visualizar/Abrir |
Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.